available for iOS, Android & web
February 19, 2014
Drug prevents debilitating drop in blood pressure in NOH patients
January 15, 2014
16-1 vote in favour of approval
February 24, 2012
Advisors to the US Food and Drug Administration have recommended approval for Forest Laboratories and Almirall’s chronic obstructive pulmonary disease drug aclidinium bromide
Recruitment agencies provide the unique bridge to [more]...
International Clinical Researcher of the Year 2016
Book your tickets today!
PharmaTimes 2015 Copyright | RSS Feed Subscriptions